Design, synthesis, and biological evaluation of harmine derivatives as topoisomerase I inhibitors for cancer treatment.

MLA

Guo, Ya-Li, et al. “Design, Synthesis, and Biological Evaluation of Harmine Derivatives as Topoisomerase I Inhibitors for Cancer Treatment.” European Journal of Medicinal Chemistry, vol. 265, Feb. 2024, p. 116061. EBSCOhost, https://doi.org/10.1016/j.ejmech.2023.116061.

APA

Guo, Y.-L., Yu, J.-W., Cao, Y., Cheng, K.-X., Dong-Zhi, S.-N.-M., Zhang, Y.-F., Ren, Q.-J., Yin, Y., & Li, C.-L. (2024). Design, synthesis, and biological evaluation of harmine derivatives as topoisomerase I inhibitors for cancer treatment. European Journal of Medicinal Chemistry, 265, 116061. https://doi.org/10.1016/j.ejmech.2023.116061

Chicago

Guo, Ya-Li, Jing-Wen Yu, Yan Cao, Ke-Xin Cheng, Suo-Nan-Mu Dong-Zhi, Yan-Fei Zhang, Qing-Jia Ren, Yong Yin, and Cao-Long Li. 2024. “Design, Synthesis, and Biological Evaluation of Harmine Derivatives as Topoisomerase I Inhibitors for Cancer Treatment.” European Journal of Medicinal Chemistry 265 (February): 116061. doi:10.1016/j.ejmech.2023.116061.